Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2012
04/03/2012US8147730 Synthesis of small particles
04/03/2012CA2624481C Anti-hypercholesterolemic compounds
04/03/2012CA2620250C A process for the removal of sterols and other compounds from glycerol oils
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
04/03/2012CA2398445C A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
03/2012
03/29/2012WO2012040465A2 Multipotent stem cells and uses thereof
03/29/2012WO2012040279A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012WO2012040082A2 Antidiabetic solid pharmaceutical compositions
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012038965A1 Dietary supplement containing morinda citrifolia (known as noni) powder and preparing method thereof
03/29/2012WO2012038785A1 Polymorphs of rosuvastatin acetonide calcium ((3r,5s,6e)-7-[4-(4- fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimn)in-5- yl)vinyl)-2,2-dimethyl-l,3-dioxan-4-yl) acetic acid calcium salt
03/29/2012WO2012038251A1 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of langerhans
03/29/2012WO2012037782A1 Tricyclic compounds, preparation methods, and their uses
03/29/2012WO2012017321A3 Treatment for dyslipidemia
03/29/2012WO2011149213A3 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient
03/29/2012WO2011140267A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
03/29/2012WO2011140132A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
03/29/2012WO2011139907A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
03/29/2012WO2011139801A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
03/29/2012WO2011139379A3 A method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities
03/29/2012WO2011130729A3 Methods for treating metabolic disorders using fgf
03/29/2012WO2010142981A3 Composition and uses thereof
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120077879 Process for making compositions with poorly compressible therapeutic compounds
03/29/2012US20120077872 Preservative-free pharmaceutical tetrahydrolipstatin compositions
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077865 Methods for treating hypercholesterolemia
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077848 Novel process to prepare pioglitazone via several novel intermediates
03/29/2012US20120077847 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
03/29/2012US20120077832 Besylate salt of a btk inhibitor
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077828 Chemical compounds
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077821 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/29/2012US20120077818 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077813 Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease
03/29/2012US20120077812 Bicyclic compounds and use as antidiabetics
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077802 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/29/2012US20120077800 Methods for Treating Antipsychotic-Induced Weight Gain
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077793 Compounds for the Treatment of Metabolic Disorders
03/29/2012US20120077792 Lanthanide metal complexes useful in treating cancer
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077780 Fat Accumulation Inhibitor and Method of Use Thereof
03/29/2012US20120077774 Compositions and their use for removing cholesterol
03/29/2012US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)
03/29/2012US20120077760 Novel salts of sitagliptin
03/29/2012US20120077746 Glp-1 analogues pharmaceutical compositions
03/29/2012US20120077739 Methods for treating obesity employing an sglt2 inhibitor and compositions thereof
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120076877 Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof
03/29/2012US20120076873 Health Food
03/29/2012US20120076861 Materials and methods for the treatment of celiac disease
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076829 Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
03/29/2012US20120076824 Novel edwardsiella ictaluri e-ict-vl33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076753 Use of nkp46 for preventing diabetes
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012CA2812061A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811634A1 Antidiabetic solid pharmaceutical compositions
03/28/2012EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome
03/28/2012EP2433932A1 Prophylactic And/Or Therapeutic Agent For Hyperlipidemia
03/28/2012EP2433650A2 Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2433629A1 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of Langerhans
03/28/2012EP2433625A1 Anti-obesity agent comprising compound containing benzotropolone ring
03/28/2012EP2433623A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
03/28/2012EP2432880A1 Targeting micrornas for metabolic disorders
03/28/2012EP2432879A1 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
03/28/2012EP2432770A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
03/28/2012EP2432490A1 Bone morphogenetic proteins for the treatment of insulin resistance
03/28/2012EP2326649B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1894919B1 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
03/28/2012EP1579872B1 Body weight gain inhibitor
03/28/2012EP1499580B1 Compounds that stimulate glucose utilization and methods of use
03/28/2012EP1272197B2 Combination of lecithin with ascorbic acid
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN1931874B Preparation process, medicine preparation and medicinal use of ginseng glycopeptide
03/28/2012CN1668287B Use of 3-deoxyflavonoids in preparing medicine for inhibition of t-lymphocyte activation
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395584A Compounds for the treatment of metabolic disorders
03/28/2012CN102395580A Crystalline polymorphic form 631
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 1298